Loading...

LIMN LIMINATUS PHARMA INC Other Situations 8-K Filing

LMNT

LMN

LIMINATUS PHARMA INC

(LIMN)

2025 8-K

Bylaw Amendment

Stock Offering Details

Settlement Agreement

Delisting Notice

Nasdaq Non-Compliance

Nasdaq Non-Compliance

Research Update

Investor Meetings

Non-Compliance Notification

Merger of Equals

Merger of Equals

External Links:

On June 24, 2025, Liminatus Pharma, Inc. provided an update on its research development programs via a press release. The company clarified that the information is not considered filed under the Exchange Act.

AI Assistant

LIMINATUS PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.